TP53 and colorectal carcinoma: Further correlations with histopathological features in the CRC cohort suggest associations of CD10 expression with aggressive CRC phenotypes, i.e., p53 positivity, which indicates accumulation of p53 mutations, as mutant p53 is more stable and, therefore, accessible for immunohistochemical staining [29], and nuclear β-catenin expression.